A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation (Q36587695)
Jump to navigation
Jump to search
scientific article published on 30 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation |
scientific article published on 30 January 2013 |
Statements
1 reference
A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation (English)
1 reference
Koen van Rossem
1 reference
Jenny A Lowe
1 reference
30 January 2013
1 reference
1 reference
23-31
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference